This paper is the forty-fifth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Objective The overarching goal of this review is to provide a clinical overview of
epidemiology, diagnosis, and treatment, and to discuss the public health impact, social …

Background Death by suicide in patients enrolled in opioid agonist therapy (OAT) is a major
clinical concern. However, little knowledge exists regarding suicide attempts in this patient …

Background As the overdose crisis continues in the US and Canada, opioid use disorder
(OUD) treatment outcomes for people with co-occurring psychiatric disorders are not well …

Background High lifetime prevalence of major mental disorders and suicidality are common
among Opioid Agonist Treatment (OAT) service users and impact on the outcomes of OAT …

Background: Opioid use disorder (OUD) disproportionately affects individuals with
schizophrenia, who are less likely to receive opioid agonist therapy (OAT) and have a …

Results Three hundred twenty-three patients with SUD and psychosis were enrolled during
the study period. Fifty (15.9%) were excluded because of incomplete data on outcome …

Substance use disorders (SUDs) are common among individuals with schizophrenia and
negatively affect the clinical course of the illness. Despite the high prevalence and …

Psychiatric Comorbidities Among Persons Who Are Using Opioids | The Oxford Handbook of
Opioids and Opioid Use Disorder | Oxford Academic Skip to Main Content Advertisement Oxford …

Ahistory of substance use is closer to a rule than an exception for people with severe mental
illness. Whether it is cigarette smoking and alcohol consumption or the use of illegal drugs …